HMG CoA Reductase Inhibitors ("Statins")

Janessa M. Smith, PharmD, BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

FDA

  • Atherosclerosis: fluvastatin, lovastatin
  • Cardiovascular events (secondary prevention): pravastatin; coronary heart disease (primary prevention): pravastatin, simvastatin, fluvastatin, lovastatin
  • Stroke / TIA (prophylaxis): simvastatin, rosuvastatin, atorvastatin
  • Hypercholesterolemia, heterozygous familial: pravastatin (pediatrics), fluvastatin, atorvastatin, lovastatin, rosuvastatin; hypercholesterolemia, homozygous familial: simvastatin, atorvastatin, rosuvastatin
  • Hypercholesterolemia (primary): fluvastatin, rosuvastatin, lovastatin, atorvastatin; hypertriglyceridemia: atorvastatin, rosuvastatin

NON-FDA APPROVED USES

  • Hyperlipidemia associated with ART

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 3, 2016